Beth Psaila/LinkedIn
Oct 19, 2026, 07:33
Beth Psaila: Highlights from IACH Annual Meeting and MPN Horizons
Beth Psaila, Senior Fellow at New College, Oxford, Co-Founder of Alethio Therapeutics, Professor of Haematology and Cancer Research UK Senior Fellow at University of Oxford, shared a post on LinkedIn:
“Grateful to The Annual Meeting of the IACH, MPN Horizons and Video Journal of Hematology and Hematological Oncology (VJHemOnc) for the opportunity to spend time in two of my favourite cities – and to talk/hear talks about two of my favourite MPN topics: G6B targeting and emerging data from mutant CALR targeting therapies!
These international workshops are great to connect with friends and colleagues across our clinical, academic, industry and patient advocacy community.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 07:36Johannes Kaesmacher: Cerebral No-Reflow After Thrombectomy Toward a Standardized Definition
-
Oct 19, 2026, 07:29Wolfgang Miesbach: Can Losartan Activate Brown Fat? – Nature Study Explores New Therapeutic Link
-
Oct 19, 2026, 07:22Ruben Mesa: Honored to Speak at the Tandem MPN Meetings of IACH
-
Oct 19, 2026, 07:19Saneha Anjum Shaikh: Parul University Partners with Raktasevak Bike Ride 2026 for Blood Donation Drive
-
Oct 19, 2026, 07:09Alejandro González Veliz: No ST Elevation Does Not Guarantee an Open Coronary Artery
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer OutcomesÂ
-
Oct 19, 2026, 05:44Mavis Agnes Kisakye: Raising Awareness about Haemophilia and Other Blood Disorders at Luweero General Hospital
-
Oct 19, 2026, 05:43Mohsen Asadi: Women and Blood Clots – Understanding Risk Across Every Life Stage